Biosimilar Monoclonal Antibodies Market Reports

Get the full Biosimilar Monoclonal Antibodies market evidence

The purchased report supplies researched market size, forecast, growth, segments, competition and sources.

Biosimilar Monoclonal Antibodies reports by place
Place	Current size	Forecast	Growth	Active trials	Report
World	In full report	In full report	In full report	456	View report
Africa	In full report	In full report	In full report	25	View report
APAC	In full report	In full report	In full report	60	View report
Australia	In full report	In full report	In full report	16	View report
Brazil	In full report	In full report	In full report	12	View report
Canada	In full report	In full report	In full report	52	View report
China	In full report	In full report	In full report	34	View report
Ecuador	In full report	In full report	In full report	0	View report
Egypt	In full report	In full report	In full report	18	View report
Europe	In full report	In full report	In full report	41	View report
France	In full report	In full report	In full report	19	View report
Germany	In full report	In full report	In full report	11	View report
Hong Kong	In full report	In full report	In full report	7	View report
India	In full report	In full report	In full report	4	View report
Italy	In full report	In full report	In full report	18	View report
Japan	In full report	In full report	In full report	14	View report
Kenya	In full report	In full report	In full report	0	View report
Latin America	In full report	In full report	In full report	68	View report
Malaysia	In full report	In full report	In full report	7	View report
Mexico	In full report	In full report	In full report	61	View report
Middle East	In full report	In full report	In full report	2	View report
New Zealand	In full report	In full report	In full report	6	View report
North America	In full report	In full report	In full report	355	View report
Philippines	In full report	In full report	In full report	5	View report
Russia	In full report	In full report	In full report	3	View report
Saudi Arabia	In full report	In full report	In full report	2	View report
Singapore	In full report	In full report	In full report	5	View report
South Africa	In full report	In full report	In full report	7	View report
Spain	In full report	In full report	In full report	18	View report
Thailand	In full report	In full report	In full report	6	View report
UAE	In full report	In full report	In full report	0	View report
UK	In full report	In full report	In full report	9	View report
US	In full report	In full report	In full report	351	View report

Public clinical research

456 active trials found worldwide on ClinicalTrials.gov.

See the public search

Latest public research

Effectiveness and Safety Outcomes After Switching from Reference Biologics to Biosimilars for Treatment of Non-Infectious Uveitis: A Systematic Review and Meta-Analysis.Clinical ophthalmology (Auckland, N.Z.), 2026
A Comparison of Two Strategies for Converting to Adalimumab Biosimilarsa.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2026
Infant-onset mevalonate kinase deficiency with a previously unreported MVK c.827 A > G (p.Glu276Gly) variant presenting as suspected incomplete kawasaki disease with marked hyperinflammation: clinical response to firsekibart and systematic evidence synthesis.Pediatric rheumatology online journal, 2026
Cost-effectiveness analysis of finotonlimab in combination with bevacizumab biosimilar SCT510 as first-line therapy for advanced hepatocellular carcinoma.Expert review of pharmacoeconomics & outcomes research, 2026
Evolving role of Anti-CD20 monoclonal antibodies in rheumatoid arthritis: efficacy, safety, economic perspectives, and future directions-a narrative review.BMC medicine, 2026

Public trial and paper counts come from ClinicalTrials.gov and PubMed. Acuitas market figures are not published on this page.

Biosimilar Monoclonal Antibodies reports

Get the full Biosimilar Monoclonal Antibodies market evidence

Public clinical research

Latest public research